-transparent.png){kind=logo}
Terconazole is a new triazole ketal derivative with broad-spectrum in vitro and in vivo antifungal activities. This study further characterizes the effects of terconazole in vitro on yeast cell growth, viability, and morphology. Terconazole inhibited the growth of Candida albicans ATCC 44859 in a concentration-related manner, but with modest effects noted at levels from 10(-8) to 10(-5) M when the yeast was grown on media favoring the cell form. The inhibitory potency of terconazole on yeast cell viability varied with the strain and species of Candida tested. The susceptibility of C. albicans ATCC 44859 to terconazole was markedly enhanced when the yeast was grown on Eagle minimum essential medium, which favors mycelium formation. The effects of terconazole on the morphology of yeast cells (grown on Eagle minimum essential medium) were shown by phase-contrast and electron microscopy. There is a progression of changes, from loss of mycelia formation at 10(-8) M terconazole through complete necrosis at 10(-4) M.
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
January 1983,
Chemotherapy,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
September 1980,
Zeitschrift fur Hautkrankheiten,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
September 1974,
Zeitschrift fur Hautkrankheiten,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
March 1972,
Die Medizinische Welt,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
August 1989,
The Journal of reproductive medicine,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
May 1979,
Experientia,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
January 1972,
Chemotherapy,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
February 1975,
Arzneimittel-Forschung,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
January 1972,
La Prensa medica mexicana,
E L Tolman, and
D M Isaacson, and
M E Rosenthale, and
J L McGuire, and
J Van Cutsem, and
M Borgers, and
H Van den Bossche
June 1969,
Deutsche medizinische Wochenschrift (1946),
